Spondyloarthropathies News

A treat-to-target strategy in which TNF inhibitors are tapered is non-inferior to a regimen without tapering for maintaining low disease activity in patients with psoriatic arthritis or axial spondyloarthritis, according to data.

Consuming specific dietary components such as vitamin D or omega-3 is “unlikely to influence the progression” of rheumatic and musculoskeletal diseases, according to a report of systemic reviews published in RMD Open.

Most patients with immune-mediated inflammatory diseases who had weakened responses to a standard vaccine series for COVID-19 mounted a serological response to a third dose, according to data published in Arthritis and Rheumatology.

Although telehealth can be useful in treating patients with rheumatic diseases, diagnoses should be established in face-to-face visits, according to new EULAR points to consider.

Patients with ankylosing spondylitis who exhibit depression and hypertension appear to demonstrate worse function and disease activity, according to data presented at EULAR 2022 Congress.

More than half of a cohort of patients with rheumatic or musculoskeletal diseases reported experiencing some post-traumatic stress outcomes during the COVID-19 pandemic, according to data presented at the EULAR 2022 Congress.

Interventions to prevent lumbar and thoracic movement restriction in patients with ankylosing spondylitis may require early intervention, as degradation seems to mainly occur in the first years of disease progression, a study found.

A two-dose vaccine course is “highly effective” against COVID-19 infection and severe outcomes in patients with rheumatoid arthritis, ankylosing spondylitis, psoriasis and inflammatory bowel disease, according to data.

Sometimes, the best way to care for a patient is to know one’s own limitations.

What is SAPHO? What does the ‘H’ stand for, again? This episode explores some basics about the condition and delves into the history of how this disease came to be.